Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpartum uterine bleeding.
Read the full article: Organon Completes Acquisition of Alydia Health //
Source: https://www.businesswire.com/news/home/20210616005260/en/Organon-Completes-Acquisition-of-Alydia-Health-%E2%80%93-A-Medical-Device-Company-Focused-on-Postpartum-Hemorrhage